1. Scrip
  2. >>Business

Celltrion Healthcare IPO To Accelerate Celltrion's Global Biosimilar Expansion

 
• By Jung Won Shin

Celltrion Healthcare's initial public offering, which is seen as the most anticipated biotech IPO in South Korea's Kosdaq market this year, is set to speed up Celltrion's expansion of its global market presence as well as the development of biosimilars and novel drugs.

Money Wave

Celltrion Healthcare Co. Ltd. has successfully completed a KRW1tn ($889.3m) IPO in South Korea's second-tier Kosdaq market, paving the way for the company to further expand its global sales networks and product portfolios.

Celltrion Healthcare, which is the global marketing and distribution arm of Celltrion Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip